672 related articles for article (PubMed ID: 23985535)
21. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the performance of PEG-PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro.
Liu Y; Liu Z; Wang Y; Liang YR; Wen X; Hu J; Yang X; Liu J; Xiao S; Cheng D
Brain Res; 2013 Jan; 1490():43-51. PubMed ID: 23103413
[TBL] [Abstract][Full Text] [Related]
23. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
[TBL] [Abstract][Full Text] [Related]
24. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
Lee H; Kim IK; Park TG
Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
[TBL] [Abstract][Full Text] [Related]
25. Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.
Wang Y; Yang C; Hu R; Toh HT; Liu X; Lin G; Yin F; Yoon HS; Yong KT
Biomater Sci; 2015 Jan; 3(1):192-202. PubMed ID: 26214202
[TBL] [Abstract][Full Text] [Related]
26. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
Kumar K; Maiti B; Kondaiah P; Bhattacharya S
Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
[TBL] [Abstract][Full Text] [Related]
27. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
30. Halloysite nanotube-based drug delivery system for treating osteosarcoma.
Sun L; Mills DK
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2920-3. PubMed ID: 25570602
[TBL] [Abstract][Full Text] [Related]
31. Cell Membrane-Coated Halloysite Nanotubes for Target-Specific Nanocarrier for Cancer Phototherapy.
Tan C; Zheng J; Feng Y; Liu M
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361636
[TBL] [Abstract][Full Text] [Related]
32. Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.
Liu J; Zhang Y; Zeng Q; Zeng H; Liu X; Wu P; Xie H; He L; Long Z; Lu X; Xiao M; Zhu Y; Bo H; Cao K
Sci Adv; 2019 Sep; 5(9):eaaw6499. PubMed ID: 31579820
[TBL] [Abstract][Full Text] [Related]
33. Naturally occurring nanotube with surface modification as biocompatible, target-specific nanocarrier for cancer phototherapy.
Li LY; Zhou YM; Gao RY; Liu XC; Du HH; Zhang JL; Ai XC; Zhang JP; Fu LM; Skibsted LH
Biomaterials; 2019 Jan; 190-191():86-96. PubMed ID: 30408640
[TBL] [Abstract][Full Text] [Related]
34. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
Cheng D; Cao N; Chen J; Yu X; Shuai X
Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
[TBL] [Abstract][Full Text] [Related]
36. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
37. Cytocompatibility and uptake of halloysite clay nanotubes.
Vergaro V; Abdullayev E; Lvov YM; Zeitoun A; Cingolani R; Rinaldi R; Leporatti S
Biomacromolecules; 2010 Mar; 11(3):820-6. PubMed ID: 20170093
[TBL] [Abstract][Full Text] [Related]
38. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
[TBL] [Abstract][Full Text] [Related]
39. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
40. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
